Working… Menu
Trial record 2 of 5 for:    "Cand5"

Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00306904
Recruitment Status : Completed
First Posted : March 27, 2006
Last Update Posted : July 25, 2008
Information provided by:
OPKO Health, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2007
Actual Study Completion Date : December 2007